http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4439604-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-14 |
| filingDate | 1982-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1984-03-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3b0293e5b05fa5426c6c3a647ba3b3 |
| publicationDate | 1984-03-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4439604-A |
| titleOfInvention | 7-β-D-Arabinofuranosyl-7H-pyrrolo[2,3-d]pyrimidine compounds and methods for their production |
| abstract | Hydroxy, amino and sulfhydryl derivatives of 7-β-D-arabinofuranosyl-7H-pyrrolo[2,3-d]pyrimidine, their corresponding esters and non-toxic pharmaceutically acceptable salts are produced by arabinofuranosylation of the requisite heterocycles with 2,3,5-tri-O-benzyl-α-D-arabinofuranosyl halide and further reaction to obtain the desired compounds. These water soluble compounds are resistant to adenosine deaminase and exhibit antiviral activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5721356-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6211158-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2360166-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2399588-A1 |
| priorityDate | 1981-01-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 164 of 164.